» Articles » PMID: 29369684

Respiratory Symptoms in Young Adults and Future Lung Disease. The CARDIA Lung Study

Abstract

Rationale: There are limited data on factors in young adulthood that predict future lung disease.

Objectives: To determine the relationship between respiratory symptoms, loss of lung health, and incident respiratory disease in a population-based study of young adults.

Methods: We examined prospective data from 2,749 participants in the CARDIA (Coronary Artery Risk Development in Young Adults) study who completed respiratory symptom questionnaires at baseline and 2 years later and repeated spirometry measurements over 30 years.

Measurements And Main Results: Cough or phlegm, episodes of bronchitis, wheeze, shortness of breath, and chest illnesses at both baseline and Year 2 were the main predictor variables in models assessing decline in FEV and FVC from Year 5 to Year 30, incident obstructive and restrictive lung physiology, and visual emphysema on thoracic computed tomography scan. After adjustment for covariates, including body mass index, asthma, and smoking, report of any symptom was associated with -2.71 ml/yr excess decline in FEV (P < 0.001) and -2.18 in FVC (P < 0.001) as well as greater odds of incident (prebronchodilator) obstructive (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.24-2.14) and restrictive (OR, 1.40; 95% CI, 1.09-1.80) physiology. Cough-related symptoms (OR, 1.56; 95% CI, 1.13-2.16) were associated with greater odds of future emphysema.

Conclusions: Persistent respiratory symptoms in young adults are associated with accelerated decline in lung function, incident obstructive and restrictive physiology, and greater odds of future radiographic emphysema.

Citing Articles

Functionally important respiratory symptoms and continued cigarette use versus e-cigarette switching: population assessment of tobacco and health study waves 2-6.

Sargent J, Lauten K, Edwards K, Tanski S, MacKenzie T, Paulin L EClinicalMedicine. 2025; 79:102951.

PMID: 39968205 PMC: 11833018. DOI: 10.1016/j.eclinm.2024.102951.


Preserved ratio impaired spirometry, airflow obstruction, and their trajectories in relationship to chronic kidney disease: a prospective cohort study.

Patel I, Zhang J, Chai Y, Qiao Y, Gong H, Xu H Sci Rep. 2025; 15(1):3439.

PMID: 39870785 PMC: 11772821. DOI: 10.1038/s41598-025-86952-6.


Physical health in young males and risk of chronic musculoskeletal, cardiovascular, and respiratory diseases by middle age: A population-based cohort study.

Turkiewicz A, Magnusson K, Timpka S, Kiadaliri A, Dell-Isola A, DellIsola A PLoS Med. 2025; 22(1):e1004517.

PMID: 39836663 PMC: 11793790. DOI: 10.1371/journal.pmed.1004517.


Associations between life-course FEV/FVC trajectories and respiratory symptoms up to middle age: analysis of data from two prospective cohort studies.

Perret J, Bui D, Pistenmaa C, Vicendese D, Khan S, Han M Lancet Respir Med. 2024; 13(2):130-140.

PMID: 39615504 PMC: 11802298. DOI: 10.1016/S2213-2600(24)00265-0.


A Joint Classification Method for COVID-19 Lesions Based on Deep Learning and Radiomics.

Ma G, Wang K, Zeng T, Sun B, Yang L Tomography. 2024; 10(9):1488-1500.

PMID: 39330755 PMC: 11435940. DOI: 10.3390/tomography10090109.


References
1.
. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet. 1965; 1(7389):775-9. View

2.
Camilli A, Burrows B, KNUDSON R, Lyle S, LEBOWITZ M . Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am Rev Respir Dis. 1987; 135(4):794-9. DOI: 10.1164/arrd.1987.135.4.794. View

3.
Urrutia I, Capelastegui A, Quintana J, Muniozguren N, Basagana X, Sunyer J . Smoking habit, respiratory symptoms and lung function in young adults. Eur J Public Health. 2005; 15(2):160-5. DOI: 10.1093/eurpub/cki113. View

4.
Washko G, Lynch D, Matsuoka S, Ross J, Umeoka S, Diaz A . Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol. 2009; 17(1):48-53. PMC: 2790552. DOI: 10.1016/j.acra.2009.07.016. View

5.
. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis. 1991; 144(5):1202-18. DOI: 10.1164/ajrccm/144.5.1202. View